GoalVest Advisory LLC Purchases 2,840 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

GoalVest Advisory LLC raised its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 2,308.9% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,963 shares of the medical equipment provider's stock after buying an additional 2,840 shares during the period. GoalVest Advisory LLC's holdings in Intuitive Surgical were worth $1,467,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently bought and sold shares of ISRG. Atala Financial Inc purchased a new position in shares of Intuitive Surgical during the fourth quarter worth about $25,000. Parvin Asset Management LLC purchased a new position in shares of Intuitive Surgical during the fourth quarter worth about $26,000. BankPlus Trust Department purchased a new position in shares of Intuitive Surgical during the fourth quarter worth about $28,000. Hurley Capital LLC purchased a new position in shares of Intuitive Surgical during the fourth quarter worth about $28,000. Finally, Summit Securities Group LLC purchased a new stake in Intuitive Surgical in the 4th quarter valued at approximately $30,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Trading Down 0.5%

ISRG traded down $3.03 on Tuesday, hitting $550.26. 413,663 shares of the company's stock were exchanged, compared to its average volume of 1,639,441. Intuitive Surgical, Inc. has a twelve month low of $397.47 and a twelve month high of $616.00. The firm has a market cap of $197.22 billion, a PE ratio of 85.84, a P/E/G ratio of 5.85 and a beta of 1.70. The stock has a fifty day moving average of $517.32 and a two-hundred day moving average of $538.73.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, topping the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The firm had revenue of $2.25 billion during the quarter, compared to analysts' expectations of $2.19 billion. During the same quarter in the prior year, the firm earned $1.50 EPS. On average, analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insiders Place Their Bets

In other news, SVP Mark Brosius sold 492 shares of the stock in a transaction that occurred on Wednesday, March 5th. The shares were sold at an average price of $554.17, for a total value of $272,651.64. Following the completion of the transaction, the senior vice president now directly owns 3,072 shares in the company, valued at $1,702,410.24. This trade represents a 13.80% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Brian Edward Miller sold 8,900 shares of the firm's stock in a transaction that occurred on Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the sale, the executive vice president now owns 5,758 shares of the company's stock, valued at $2,793,033.06. The trade was a 60.72% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 25,778 shares of company stock worth $12,867,197. Insiders own 0.70% of the company's stock.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on ISRG. Royal Bank of Canada lowered their price objective on Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating on the stock in a report on Wednesday, April 23rd. Truist Financial lowered their price objective on Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating on the stock in a report on Wednesday, April 23rd. Erste Group Bank lowered Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a report on Monday, March 17th. BTIG Research set a $560.00 price objective on Intuitive Surgical and gave the stock a "buy" rating in a research report on Monday, April 14th. Finally, Evercore ISI lowered their price objective on shares of Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating for the company in a research note on Wednesday, April 23rd. Five investment analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $596.05.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.